Arraying autoimmunity treatment
Protein arrays offer great promise for profiling changes in protein levels and composition to develop new biomarkers for early diagnosis of disease and to design new treatments. But can the mass of data collected in such experiments be applied to practical, clinical use? In an exciting advance, Robi...
Gespeichert in:
Veröffentlicht in: | Nature biotechnology 2003-09, Vol.21 (9), p.1017-1019 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1019 |
---|---|
container_issue | 9 |
container_start_page | 1017 |
container_title | Nature biotechnology |
container_volume | 21 |
creator | Sercarz, Eli E |
description | Protein arrays offer great promise for profiling changes in protein levels and composition to develop new biomarkers for early diagnosis of disease and to design new treatments. But can the mass of data collected in such experiments be applied to practical, clinical use? In an exciting advance, Robinson et al. report in this issue the use of protein microarrays to predict and design a multicomponent protective DNA vaccine against an autoimmune disease. By revealing the spectrum of antibodies raised in individual mice during an autoimmune disease, microarray analysis is exploited to predict the relevant autoantigen cDNAs for inclusion in DNA vaccines. The authors demonstrate that superior protection is afforded by vaccines which raise the largest diversity of antibodies. |
doi_str_mv | 10.1038/nbt0903-1017 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_73608164</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A190182399</galeid><sourcerecordid>A190182399</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-afb4fde563c32fd05b0e43fa335a3ec3823c35d51434622fb805e321eb4061f3</originalsourceid><addsrcrecordid>eNqN0d9LHDEQB_AgFX-cffO5FR8KBdfO5NdtHg-prSAIKr6G7O7kWLnN2iQL3n9v5A5EKbTkISHzyZDhy9gxwjmCqH-EJoMBUSHgfIcdoJK6Qm30p3KGel4BKr3PDlN6BAAttd5j-8iNNEqrA_Z1EaNb92F54qY89sMwhT6vT3IklwcK-YjterdK9Hm7z9j95c_7i9_V9c2vq4vFddVKA7lyvpG-I6VFK7jvQDVAUngnhHKCWlHzUlCdQimk5tw3NSgSHKmRoNGLGfu2afsUxz8TpWyHPrW0WrlA45TsXGioUct_QqxrbjTqAk8_wMdxiqHMYDnnAuam_GnGzjdo6VZk--DHHF1bVkdD346BfF_uF2gAizamPPj-7kExmZ7z0k0p2au72_-3Nw_v7dnGtnFMKZK3T7EfXFxbBPsas93GbF9jLvzLdripGah7w9tcC6g2IJVSWFJ8m_6vDV8ARCGtNQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222307982</pqid></control><display><type>article</type><title>Arraying autoimmunity treatment</title><source>MEDLINE</source><source>Nature Journals Online</source><source>SpringerLink Journals - AutoHoldings</source><creator>Sercarz, Eli E</creator><creatorcontrib>Sercarz, Eli E</creatorcontrib><description>Protein arrays offer great promise for profiling changes in protein levels and composition to develop new biomarkers for early diagnosis of disease and to design new treatments. But can the mass of data collected in such experiments be applied to practical, clinical use? In an exciting advance, Robinson et al. report in this issue the use of protein microarrays to predict and design a multicomponent protective DNA vaccine against an autoimmune disease. By revealing the spectrum of antibodies raised in individual mice during an autoimmune disease, microarray analysis is exploited to predict the relevant autoantigen cDNAs for inclusion in DNA vaccines. The authors demonstrate that superior protection is afforded by vaccines which raise the largest diversity of antibodies.</description><identifier>ISSN: 1087-0156</identifier><identifier>EISSN: 1546-1696</identifier><identifier>DOI: 10.1038/nbt0903-1017</identifier><identifier>PMID: 12949565</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Agriculture ; Animals ; Bioinformatics ; Biomedical and Life Sciences ; Biomedical Engineering/Biotechnology ; Biomedicine ; Biotechnology ; Drug Tolerance ; Encephalomyelitis, Autoimmune, Experimental - diagnosis ; Encephalomyelitis, Autoimmune, Experimental - drug therapy ; Encephalomyelitis, Autoimmune, Experimental - immunology ; Immunoassay - methods ; Life Sciences ; Mice ; Multiple Sclerosis - diagnosis ; Multiple Sclerosis - drug therapy ; Multiple Sclerosis - immunology ; Myelin Sheath - immunology ; news-and-views ; Protein Array Analysis - methods ; Protein Interaction Mapping - methods ; Treatment Outcome ; Vaccines, DNA - immunology ; Vaccines, DNA - therapeutic use</subject><ispartof>Nature biotechnology, 2003-09, Vol.21 (9), p.1017-1019</ispartof><rights>Springer Nature America, Inc. 2003</rights><rights>COPYRIGHT 2003 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Sep 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-afb4fde563c32fd05b0e43fa335a3ec3823c35d51434622fb805e321eb4061f3</citedby><cites>FETCH-LOGICAL-c490t-afb4fde563c32fd05b0e43fa335a3ec3823c35d51434622fb805e321eb4061f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nbt0903-1017$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nbt0903-1017$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12949565$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sercarz, Eli E</creatorcontrib><title>Arraying autoimmunity treatment</title><title>Nature biotechnology</title><addtitle>Nat Biotechnol</addtitle><addtitle>Nat Biotechnol</addtitle><description>Protein arrays offer great promise for profiling changes in protein levels and composition to develop new biomarkers for early diagnosis of disease and to design new treatments. But can the mass of data collected in such experiments be applied to practical, clinical use? In an exciting advance, Robinson et al. report in this issue the use of protein microarrays to predict and design a multicomponent protective DNA vaccine against an autoimmune disease. By revealing the spectrum of antibodies raised in individual mice during an autoimmune disease, microarray analysis is exploited to predict the relevant autoantigen cDNAs for inclusion in DNA vaccines. The authors demonstrate that superior protection is afforded by vaccines which raise the largest diversity of antibodies.</description><subject>Agriculture</subject><subject>Animals</subject><subject>Bioinformatics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering/Biotechnology</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Drug Tolerance</subject><subject>Encephalomyelitis, Autoimmune, Experimental - diagnosis</subject><subject>Encephalomyelitis, Autoimmune, Experimental - drug therapy</subject><subject>Encephalomyelitis, Autoimmune, Experimental - immunology</subject><subject>Immunoassay - methods</subject><subject>Life Sciences</subject><subject>Mice</subject><subject>Multiple Sclerosis - diagnosis</subject><subject>Multiple Sclerosis - drug therapy</subject><subject>Multiple Sclerosis - immunology</subject><subject>Myelin Sheath - immunology</subject><subject>news-and-views</subject><subject>Protein Array Analysis - methods</subject><subject>Protein Interaction Mapping - methods</subject><subject>Treatment Outcome</subject><subject>Vaccines, DNA - immunology</subject><subject>Vaccines, DNA - therapeutic use</subject><issn>1087-0156</issn><issn>1546-1696</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqN0d9LHDEQB_AgFX-cffO5FR8KBdfO5NdtHg-prSAIKr6G7O7kWLnN2iQL3n9v5A5EKbTkISHzyZDhy9gxwjmCqH-EJoMBUSHgfIcdoJK6Qm30p3KGel4BKr3PDlN6BAAttd5j-8iNNEqrA_Z1EaNb92F54qY89sMwhT6vT3IklwcK-YjterdK9Hm7z9j95c_7i9_V9c2vq4vFddVKA7lyvpG-I6VFK7jvQDVAUngnhHKCWlHzUlCdQimk5tw3NSgSHKmRoNGLGfu2afsUxz8TpWyHPrW0WrlA45TsXGioUct_QqxrbjTqAk8_wMdxiqHMYDnnAuam_GnGzjdo6VZk--DHHF1bVkdD346BfF_uF2gAizamPPj-7kExmZ7z0k0p2au72_-3Nw_v7dnGtnFMKZK3T7EfXFxbBPsas93GbF9jLvzLdripGah7w9tcC6g2IJVSWFJ8m_6vDV8ARCGtNQ</recordid><startdate>20030901</startdate><enddate>20030901</enddate><creator>Sercarz, Eli E</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20030901</creationdate><title>Arraying autoimmunity treatment</title><author>Sercarz, Eli E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-afb4fde563c32fd05b0e43fa335a3ec3823c35d51434622fb805e321eb4061f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Agriculture</topic><topic>Animals</topic><topic>Bioinformatics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering/Biotechnology</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Drug Tolerance</topic><topic>Encephalomyelitis, Autoimmune, Experimental - diagnosis</topic><topic>Encephalomyelitis, Autoimmune, Experimental - drug therapy</topic><topic>Encephalomyelitis, Autoimmune, Experimental - immunology</topic><topic>Immunoassay - methods</topic><topic>Life Sciences</topic><topic>Mice</topic><topic>Multiple Sclerosis - diagnosis</topic><topic>Multiple Sclerosis - drug therapy</topic><topic>Multiple Sclerosis - immunology</topic><topic>Myelin Sheath - immunology</topic><topic>news-and-views</topic><topic>Protein Array Analysis - methods</topic><topic>Protein Interaction Mapping - methods</topic><topic>Treatment Outcome</topic><topic>Vaccines, DNA - immunology</topic><topic>Vaccines, DNA - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sercarz, Eli E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sercarz, Eli E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Arraying autoimmunity treatment</atitle><jtitle>Nature biotechnology</jtitle><stitle>Nat Biotechnol</stitle><addtitle>Nat Biotechnol</addtitle><date>2003-09-01</date><risdate>2003</risdate><volume>21</volume><issue>9</issue><spage>1017</spage><epage>1019</epage><pages>1017-1019</pages><issn>1087-0156</issn><eissn>1546-1696</eissn><abstract>Protein arrays offer great promise for profiling changes in protein levels and composition to develop new biomarkers for early diagnosis of disease and to design new treatments. But can the mass of data collected in such experiments be applied to practical, clinical use? In an exciting advance, Robinson et al. report in this issue the use of protein microarrays to predict and design a multicomponent protective DNA vaccine against an autoimmune disease. By revealing the spectrum of antibodies raised in individual mice during an autoimmune disease, microarray analysis is exploited to predict the relevant autoantigen cDNAs for inclusion in DNA vaccines. The authors demonstrate that superior protection is afforded by vaccines which raise the largest diversity of antibodies.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>12949565</pmid><doi>10.1038/nbt0903-1017</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1087-0156 |
ispartof | Nature biotechnology, 2003-09, Vol.21 (9), p.1017-1019 |
issn | 1087-0156 1546-1696 |
language | eng |
recordid | cdi_proquest_miscellaneous_73608164 |
source | MEDLINE; Nature Journals Online; SpringerLink Journals - AutoHoldings |
subjects | Agriculture Animals Bioinformatics Biomedical and Life Sciences Biomedical Engineering/Biotechnology Biomedicine Biotechnology Drug Tolerance Encephalomyelitis, Autoimmune, Experimental - diagnosis Encephalomyelitis, Autoimmune, Experimental - drug therapy Encephalomyelitis, Autoimmune, Experimental - immunology Immunoassay - methods Life Sciences Mice Multiple Sclerosis - diagnosis Multiple Sclerosis - drug therapy Multiple Sclerosis - immunology Myelin Sheath - immunology news-and-views Protein Array Analysis - methods Protein Interaction Mapping - methods Treatment Outcome Vaccines, DNA - immunology Vaccines, DNA - therapeutic use |
title | Arraying autoimmunity treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T21%3A57%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Arraying%20autoimmunity%20treatment&rft.jtitle=Nature%20biotechnology&rft.au=Sercarz,%20Eli%20E&rft.date=2003-09-01&rft.volume=21&rft.issue=9&rft.spage=1017&rft.epage=1019&rft.pages=1017-1019&rft.issn=1087-0156&rft.eissn=1546-1696&rft_id=info:doi/10.1038/nbt0903-1017&rft_dat=%3Cgale_proqu%3EA190182399%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222307982&rft_id=info:pmid/12949565&rft_galeid=A190182399&rfr_iscdi=true |